Authors: | Lorigan, P.; Ascierto, P. A.; Dummer, R.; Eggermont, A. M.; Flaherty, K. T.; Garbe, C.; Gogas, H.; Hauschild, A.; Kefford, R. F.; Kirkwood, J. M.; Larkin, J.; Long, G. V.; Maio, M.; McArthur, G. A.; Ribas, A.; Robert, C.; Schadendorf, D.; Sondak, V. K.; Wolchok, J. D.; Hudson, A. M. |
Article Title: | Expanded access programmes: Patient interests versus clinical trial integrity |
Keywords: | survival; ipilimumab; tremelimumab; advanced melanoma; nivolumab |
Journal Title: | Lancet Oncology |
Volume: | 16 |
Issue: | 1 |
ISSN: | 1470-2045 |
Publisher: | Elsevier Science, Inc. |
Date Published: | 2015-01-01 |
Start Page: | 15 |
End Page: | 17 |
Language: | English |
ACCESSION: | WOS:000346912800038 |
PROVIDER: | wos |
PUBMED: | 25638540 |
DOI: | 10.1016/S1470-2045(14)71161-1 |
Notes: | Editorial Material -- Source: Wos |